These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Antimicrobial agents in eyedrops]. Sklubalová Z Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731 [TBL] [Abstract][Full Text] [Related]
23. [Considerations for the control of ophthalmic tubes with aluminum varnish]. Herman F; Aerts A; Alexis J; Barbe ; Baudon P; Delattre L; Leloup J; Stein E; Van den Eeckhout E J Pharm Belg; 1972; 27(4):480-92. PubMed ID: 4681078 [No Abstract] [Full Text] [Related]
24. [Preparation and filling of eyedrops]. Wolff D Pharm Prax; 1970; 3():58-9. PubMed ID: 5430539 [No Abstract] [Full Text] [Related]
25. [Advances in pharmaceutical technology in the years 1972 and 1973]. Chalabala M; Burelová A; Heliová M; Lichnerová I; Rak J; Slaný J Cesk Farm; 1974 Dec; 23(10):421-46. PubMed ID: 4455405 [No Abstract] [Full Text] [Related]
26. Preservatives in eye drops. Barkman R; Germanis M; Karpe G; Malmborg S Acta Ophthalmol (Copenh); 1969; 47(3):461-75. PubMed ID: 4899981 [No Abstract] [Full Text] [Related]
29. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate. Kodym A; Marcinkowski A; Kukuła H Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365 [TBL] [Abstract][Full Text] [Related]
30. [The packaging of eye-, ear- and nose drops]. Paris GA Pharm Weekbl; 1972 Nov; 107(46):706-10. PubMed ID: 4640024 [No Abstract] [Full Text] [Related]
31. Studies on in-use microbial contamination of eye drops. Aslund B; Olson OT; Sandell E Acta Pharm Suec; 1978; 15(5):389-94. PubMed ID: 747097 [No Abstract] [Full Text] [Related]
32. Guidelines for the preparation of sterile ophthalmic products. Reynolds LA Am J Hosp Pharm; 1991 Nov; 48(11):2438-9. PubMed ID: 1746580 [No Abstract] [Full Text] [Related]
33. Eye drops for rural populations. Taylor J World Health Forum; 1993; 14(1):63-6. PubMed ID: 8439380 [No Abstract] [Full Text] [Related]
34. Not again! Only ocular treatments should be packaged like eye drops. Wilson T BMJ; 2001 Mar; 322(7285):549. PubMed ID: 11230088 [No Abstract] [Full Text] [Related]
36. [Possibilities of use of single dose packaging for liquids]. Asp P; Franz H; Klingelhöller W Med Monatsschr; 1977 Dec; 31(12):544-54. PubMed ID: 593218 [No Abstract] [Full Text] [Related]
37. [Sterilization and stability of idoxuridine containing ophthalmic solutions]. Backer ET; van de Langerijt JJ Pharm Weekbl; 1966 Jun; 101(22):489-96. PubMed ID: 5940164 [No Abstract] [Full Text] [Related]
39. Microbiological control in the manufacture of sterile pharmaceutical products. Bühlmann X Pharm Acta Helv; 1971 Jul; 46(7):385-409. PubMed ID: 4934853 [No Abstract] [Full Text] [Related]
40. [Studies on hyaluronic acid as dendifier in Shuanghuanglian eye-drops]. Ma ML; Liu L; Sun SY Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1246-8. PubMed ID: 16245899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]